US$ 24.10
gsk glp 1 agonist The promise of GLP-1 receptor agonists for neurodegenerative diseases The Beneficial Effects of GLP-1
Description
doi: 10.3233/JAD-210256 [DOI] [PubMed] [Google Scholar] 236

Ishy, P

M., Van Raalte, D

If the patient is experiencing gastrointestinal symptoms, EMS personnel should assess for recent increase in dose with their prescribed semaglutide medications, as increasing the dose of semaglutide medications may trigger gastrointestinal symptoms

Hydration requires particular attention, as patients may experience reduced oral intake due to nausea or early satiety
